ARTICLE | Company News
Prosetta Biosciences, Takeda deal
May 23, 2016 7:00 AM UTC
Prosetta and Takeda partnered to conduct a feasibility study for the development of therapies against an undisclosed target to treat a neurodegenerative disease. Takeda will have exclusive negotiation...